chr10-117241640-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003054.6(SLC18A2):c.-15-39A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.991 in 1,504,598 control chromosomes in the GnomAD database, including 739,812 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.95 ( 69485 hom., cov: 33)
Exomes 𝑓: 1.0 ( 670327 hom. )
Consequence
SLC18A2
NM_003054.6 intron
NM_003054.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.241
Genes affected
SLC18A2 (HGNC:10935): (solute carrier family 18 member A2) This gene encodes an transmembrane protein that functions as an ATP-dependent transporter of monoamines, such as dopamine, norepinephrine, serotonin, and histamine. This protein transports amine neurotransmitters into synaptic vesicles. Polymorphisms in this gene may be associated with schizophrenia, bipolar disorder, and other neurological/psychiatric ailments. [provided by RefSeq, Jun 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 10-117241640-A-C is Benign according to our data. Variant chr10-117241640-A-C is described in ClinVar as [Benign]. Clinvar id is 1227431.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC18A2 | NM_003054.6 | c.-15-39A>C | intron_variant | ENST00000644641.2 | NP_003045.2 | |||
SLC18A2-AS1 | NR_184309.1 | n.113+245T>G | intron_variant, non_coding_transcript_variant | |||||
SLC18A2-AS1 | NR_184310.1 | n.236+21T>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC18A2 | ENST00000644641.2 | c.-15-39A>C | intron_variant | NM_003054.6 | ENSP00000496339 | P1 | ||||
SLC18A2-AS1 | ENST00000425264.2 | n.237+21T>G | intron_variant, non_coding_transcript_variant | 3 | ||||||
SLC18A2 | ENST00000497497.1 | n.129-39A>C | intron_variant, non_coding_transcript_variant | 2 | ||||||
SLC18A2-AS1 | ENST00000691914.2 | n.113+245T>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.953 AC: 144885AN: 151958Hom.: 69439 Cov.: 33
GnomAD3 genomes
AF:
AC:
144885
AN:
151958
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.995 AC: 1346087AN: 1352532Hom.: 670327 Cov.: 39 AF XY: 0.996 AC XY: 663890AN XY: 666624
GnomAD4 exome
AF:
AC:
1346087
AN:
1352532
Hom.:
Cov.:
39
AF XY:
AC XY:
663890
AN XY:
666624
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.953 AC: 144984AN: 152066Hom.: 69485 Cov.: 33 AF XY: 0.956 AC XY: 71072AN XY: 74348
GnomAD4 genome
AF:
AC:
144984
AN:
152066
Hom.:
Cov.:
33
AF XY:
AC XY:
71072
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3429
AN:
3462
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 14, 2021 | - - |
Brain dopamine-serotonin vesicular transport disease Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at